14,939 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

Posted by Alphonse Anthony on Feb 21st, 2025

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Grail, Inc. (NASDAQ:GRAL – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 14,939 shares of the company’s stock, valued at approximately $244,000.

Several other hedge funds also recently made changes to their positions in GRAL. FNY Investment Advisers LLC purchased a new position in Grail during the 4th quarter valued at $26,000. Wilmington Savings Fund Society FSB purchased a new position in Grail during the 4th quarter valued at $64,000. Manchester Capital Management LLC purchased a new position in Grail during the 4th quarter valued at $123,000. China Universal Asset Management Co. Ltd. purchased a new position in Grail during the 4th quarter valued at $127,000. Finally, Gladstone Institutional Advisory LLC purchased a new position in Grail during the 4th quarter valued at $259,000.

Analyst Ratings Changes

A number of brokerages have issued reports on GRAL. Morgan Stanley began coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock. Wolfe Research began coverage on shares of Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock.

Check Out Our Latest Stock Analysis on Grail

Grail Trading Down 9.2 %

Shares of Grail stock opened at $47.76 on Friday. The firm’s 50-day moving average is $26.32 and its 200 day moving average is $19.06. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99.

Grail (NASDAQ:GRAL – Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. Equities analysts expect that Grail, Inc. will post -65.16 EPS for the current year.

About Grail

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.